920 related articles for article (PubMed ID: 29929470)
21. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of astaxanthin on ANCA-associated vasculitis.
Sun RL; Shang JC; Han RH; Xing GQ
Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
[TBL] [Abstract][Full Text] [Related]
23. The net effect of ANCA on neutrophil extracellular trap formation.
Heeringa P; Rutgers A; Kallenberg CGM
Kidney Int; 2018 Jul; 94(1):14-16. PubMed ID: 29933842
[TBL] [Abstract][Full Text] [Related]
24. An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract.
Hasegawa J; Wakai S; Kono M; Imaizumi Y; Masuda S; Ishizu A; Honda K
Intern Med; 2018 Sep; 57(18):2739-2745. PubMed ID: 29709950
[TBL] [Abstract][Full Text] [Related]
25. Autophagy is induced by anti-neutrophil cytoplasmic Abs and promotes neutrophil extracellular traps formation.
Sha LL; Wang H; Wang C; Peng HY; Chen M; Zhao MH
Innate Immun; 2016 Nov; 22(8):658-665. PubMed ID: 27670946
[TBL] [Abstract][Full Text] [Related]
26. Possible implication of disordered neutrophil extracellular traps in the pathogenesis of MPO-ANCA-associated vasculitis.
Nakazawa D; Tomaru U; Ishizu A
Clin Exp Nephrol; 2013 Oct; 17(5):631-633. PubMed ID: 23224024
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis.
Uozumi R; Iguchi R; Masuda S; Nishibata Y; Nakazawa D; Tomaru U; Ishizu A
Mod Rheumatol; 2020 May; 30(3):544-550. PubMed ID: 30932727
[No Abstract] [Full Text] [Related]
28. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
29. Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wang H; Sha LL; Ma TT; Zhang LX; Chen M; Zhao MH
PLoS One; 2016; 11(2):e0148197. PubMed ID: 26840412
[TBL] [Abstract][Full Text] [Related]
30. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
[TBL] [Abstract][Full Text] [Related]
31. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
Huang YM; Wang H; Wang C; Chen M; Zhao MH
Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
[TBL] [Abstract][Full Text] [Related]
32. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
33. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
[TBL] [Abstract][Full Text] [Related]
35. CD47 blockade ameliorates autoimmune vasculitis via efferocytosis of neutrophil extracellular traps.
Shiratori-Aso S; Nakazawa D; Kudo T; Kanda M; Ueda Y; Watanabe-Kusunoki K; Nishio S; Iwasaki S; Tsuji T; Masuda S; Tomaru U; Ishizu A; Atsumi T
JCI Insight; 2023 Aug; 8(15):. PubMed ID: 37368493
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
[TBL] [Abstract][Full Text] [Related]
37. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
[TBL] [Abstract][Full Text] [Related]
38. Involvement of neutrophil extracellular traps in the pathogenesis of glomerulonephritis in a case of systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome.
Senda A; Sasai R; Kato K; Nishibata Y; Masuda S; Ishizu A; Takahara N
CEN Case Rep; 2022 Aug; 11(3):339-346. PubMed ID: 35025058
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil Extracellular Traps Contain Selected Antigens of Anti-Neutrophil Cytoplasmic Antibodies.
Panda R; Krieger T; Hopf L; Renné T; Haag F; Röber N; Conrad K; Csernok E; Fuchs TA
Front Immunol; 2017; 8():439. PubMed ID: 28450870
[TBL] [Abstract][Full Text] [Related]
40. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
